Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

DNA-binding activities of compounds acting as enzyme inhibitors, ion channel blockers and receptor binders

  • Ruslans Muhamadejevs
  • , Lada Živković
  • , Maija Dzintare
  • , Nikolajs Sjakste*
  • *Šī darba korespondējošais autors
  • Latvian Institute of Organic Synthesis
  • University of Belgrade
  • Latvian Academy of Sport Education

Zinātniskās darbības rezultāts: Devums žurnālamPārskata rakstskoleģiāli recenzēts

7 Atsauces (Scopus)

Kopsavilkums

The DNA-binding activities of compounds used as remedies can display DNA-protection, but also damaging effects in biological systems. The current review compiles literature data on DNA-binding activities of drugs widely used as remedies with different therapeutic indications. The compounds are classified according their mechanism of action: enzyme inhibitors, ion channel inhibitors, inhibitors of viral RNA replication and HIV protease and receptor agonists. DNA binding was reported for such widely used drugs as paracetamol, aspirin, metformin, statins and many others. The capability of the drug to bind DNA is sometimes coupled to genotoxic effects, but in some cases - to genome protection. Data on atoms and chemical groups involved in the drug-DNA interactions are also presented. In many cases the same atoms are involved in both interactions of the compounds with proteins and DNA.

OriģinālvalodaAngļu
Raksta numurs109638
ŽurnālsChemico-Biological Interactions
Sējums348
DOIs
Publikācijas statussPublicēts - 1 okt. 2021

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

OECD Zinātnes nozare

  • 1.6 Bioloģija

Nospiedums

Uzziniet vairāk par pētniecības tēmām “DNA-binding activities of compounds acting as enzyme inhibitors, ion channel blockers and receptor binders”. Kopā tie veido unikālu nospiedumu.

Citēt šo